About us

Eugin Group takes a landmark step in its growth strategy with the acquisition of Instituto Bernabeu, creating the second largest fertility group in Spain. Founded in Alicante in 1985 by Dr. Rafael Bernabeu, Instituto Bernabeu has built a reputation over four decades as one of the most respected names in the field, with 9 clinics across Spain and Italy and a legacy of clinical innovation, genetic medicine, and patient-centred care.

In Brasil, we welcome Fertipraxis, based in Rio de Janeiro, to the Huntington Group. A move that reinforces our commitment to medical excellence, innovation, and responsible care in human reproduction.

These acquisitions mark another decisive step in Eugin Group’s ongoing commitment to growth, building a stronger, larger organisation capable of shaping the future of reproductive medicine worldwide.

Our Huntington Group in Brazil acquires Clínica Fertilidade e Vida, a leading reproductive medicine centre based in Campinas, São Paulo. Founded and led by Dr. Carlos Petta. The clinic joins Eugin Group’s global network of centres, united by a shared commitment to medical excellence, innovation, and compassionate care in reproductive health.

In Spain, we created bLIVF, a boutique fertility clinic in Barcelona developed in partnership with Dr. Iñaki González Foruria and Dr. Rebeca Beguería. Unlike bigger clinics, bLIVF is built around an intentionally small, dedicated medical team that allows for the kind of close, personalised care that some patients seek in their fertility journey.

By the end of 2023, GED Capital acquires Eugin Group’s clinic network across Europe and South America, marking a defining milestone in the Group’s history. One of Spain’s leading private equity firms, with over 25 years of experience investing in high-growth sectors, GED Capital brings the strategic backing and long-term vision to accelerate Eugin’s expansion on a global scale.

The acquisition reinforces Eugin Group’s capacity to grow its brand into new geographies and strengthen its footprint in markets where demand for advanced reproductive medicine continues to rise. It also reflects the sector’s growing maturity and the confidence of institutional investors in Eugin’s clinical model and track record.

Eugin opens a new clinic in Coimbra, Portugal, a city with deep-rooted ties to healthcare and medical research. Portugal’s open-ID donation legislation makes it a particularly sought-after destination for patients seeking fertility treatments.

The Coimbra clinic occupies a purpose-built facility equipped with the latest advances in medical technology, patient care, and laboratory and surgical infrastructure. It is led by Professor Teresa Almeida Santos, distinguished by the Portuguese Ministry of Health, and staffed by a multilingual team dedicated to the highest standards of clinical excellence.

In April 2021, the Eugin Group was acquired by Fresenius, the leading German multinational in private healthcare. Fresenius Helios, which is dedicated to hospital management, acquired the entire Eugin Group, becoming its fertility and assisted reproduction division. In the same year, one of Canada’s leading centres, TRIO Fertility, joined the Group. Four new centres in the United States were also added: Ohio Reproductive Medicine Columbus, Ohio), Reproductive Care Center (Salt lake City, Utah), Wilmington Fertility Center (Wilmington, New Carolina) , and Delaware Institute for Reproductive Medicine (Newark, Delaware). The group’s presence in Brazil was also further strengthened by the Cenafert and Fertilcare centres.

In Latin America, the Group continued to grow, with the addition of Cegyr, located in the centre of Buenos Aires and market leader in the country.

In one of the most important years for the Group’s growth: The Eugin Group made its way into the United States market as a result of the entry into the Group of Boston IVF, a huge partner with a large network of 29 facilities operating in Massachusetts, Maine, Rhode Island, New Hampshire, New York, and Indiana. In Italy, the group gained a foothold in the south of the country with the acquisition of CREA in the Puglia region. In Northern Europe, 4 centres were acquired in Sweden: Nordic IVF and Stockholm IVF, and one in Latvia, called AVA Clinic.

The Eugin Group also continued to grow in Spain, in conjunction with FecunMed, which broadened its healthcare services to local patients in Catalonia.

Copenhagen Fertility Center, based in Denmark joined the Group. In Spain, the Group made a great leap forward and opened the first Eugin clinic in the country’s capital: Eugin Madrid came into being In South America, Huntington Medicina Reproductiva was added and the Group now has a foothold in Brazil.

There were changes in the ownership of the Eugin Group, which was taken over by the international hospital group NMC Healthcare, based in the United Arab Emirates. This marked the start of a period of intense growth:

• Italy became part of the Group, with the opening of a new Eugin Modena facility and the incorporation of the 2 Biogenesi clinics.
• The CIRH Clinic in Barcelona, Spain, was acquired, which brought to the Spanish Group a wealth of knowledge of local patients based on more than 30 years of experience in the market.

Eugin opened up to the world and brought its first partner into the Group: the Medifértil clinic, which would become Eugin Colombia

From this moment on, the Eugin Group’s exponential development began.

Eugin Group’s expansion and growth.

Foundation of Eugin in Barcelona, an internationally renowned facility that quickly became a benchmark in Europe and the world, treating patients from over 70 countries.